Investors Research Corp’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $688K | Sell |
44,519
-400
| -0.9% | -$6.18K | 0.13% | 162 |
|
|
2025
Q1 | $668K | Buy |
44,919
+1,725
| +4% | +$25.7K | 0.14% | 155 |
|
|
2024
Q4 | $572K | Sell |
43,194
-2,600
| -6% | -$34.4K | 0.13% | 177 |
|
|
2024
Q3 | $651K | Hold |
45,794
| – | – | 0.14% | 173 |
|
|
2024
Q2 | $593K | Hold |
45,794
| – | – | 0.14% | 181 |
|
|
2024
Q1 | $636K | Sell |
45,794
-2,012
| -4% | -$27.9K | 0.15% | 177 |
|
|
2023
Q4 | $682K | Sell |
47,806
-313
| -0.7% | -$4.47K | 0.16% | 160 |
|
|
2023
Q3 | $744K | Hold |
48,119
| – | – | 0.19% | 140 |
|
|
2023
Q2 | $756K | Sell |
48,119
-2,000
| -4% | -$31.4K | 0.19% | 144 |
|
|
2023
Q1 | $826K | Hold |
50,119
| – | – | 0.21% | 125 |
|
|
2022
Q4 | $782K | Sell |
50,119
-200
| -0.4% | -$3.12K | 0.21% | 128 |
|
|
2022
Q3 | $653K | Hold |
50,319
| – | – | 0.2% | 143 |
|
|
2022
Q2 | $706K | Buy |
50,319
+3,450
| +7% | +$48.4K | 0.21% | 140 |
|
|
2022
Q1 | $671K | Buy |
46,869
+12,900
| +38% | +$185K | 0.19% | 146 |
|
|
2021
Q4 | $463K | Buy |
33,969
+10,003
| +42% | +$136K | 0.14% | 196 |
|
|
2021
Q3 | $393K | Hold |
23,966
| – | – | 0.13% | 205 |
|
|
2021
Q2 | $403K | Hold |
23,966
| – | – | 0.14% | 203 |
|
|
2021
Q1 | $438K | Sell |
23,966
-1,075
| -4% | -$19.6K | 0.17% | 191 |
|
|
2020
Q4 | $456K | Buy |
25,041
+450
| +2% | +$8.2K | 0.18% | 192 |
|
|
2020
Q3 | $439K | Buy |
24,591
+23,550
| +2,262% | +$420K | 0.21% | 153 |
|
|
2020
Q2 | $19K | Hold |
1,041
| – | – | 0.01% | 688 |
|
|
2020
Q1 | $16K | Hold |
1,041
| – | – | 0.01% | 676 |
|
|
2019
Q4 | $21K | Hold |
1,041
| – | – | 0.01% | 704 |
|
|
2019
Q3 | $18K | Hold |
1,041
| – | – | 0.01% | 732 |
|
|
2019
Q2 | $18K | Hold |
1,041
| – | – | 0.01% | 724 |
|
|
2019
Q1 | $21K | Buy |
+1,041
| New | +$21K | 0.01% | 671 |
|